| |
| |
|
| Insider
Information: |
Grais Linda S |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
32,500 |
|
|
Indirect Shares
|
491,889 |
|
|
| Direct
Value |
$22,305 |
|
|
|
Indirect Value
|
$163,947 |
|
|
| Total
Shares |
524,389 |
|
|
| Total
Value |
$186,251 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -18.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nuvelo Inc |
ABIO |
Director |
|
0 |
2010-03-29 |
491,889 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
President and CEO, Dir... |
2017-12-11 |
0 |
2014-07-11 |
0 |
Premium* |
|
|
Pra Health Sciences, Inc. |
PRAH |
Director |
2021-07-01 |
0 |
2015-10-12 |
0 |
Premium* |
|
|
Zosano Pharma Corp |
ZSAN |
Director |
2021-06-10 |
22,500 |
2021-06-10 |
0 |
Premium* |
|
|
Corvus Pharmaceuticals, Inc. |
CRVS |
|
2023-05-15 |
10,000 |
2023-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRVS |
Corvus Pharmaceuticals, I... |
|
• • – |
2023-05-15 |
4 |
B |
$2.45 |
$24,500 |
D/D |
10,000 |
10,000 |
0.01 |
% |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2021-07-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,683) |
0 |
0 |
- |
|
| ZSAN |
Zosano Pharma Corp |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
22,500 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
250 |
9,683 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,324 |
9,433 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2019-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,436 |
8,109 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2018-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,307 |
6,673 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
President and CEO |
• • – |
2017-12-11 |
4 |
D |
$1.52 |
$456,000 |
D/D |
(300,000) |
0 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2017-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,318 |
5,366 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
President and CEO |
• • – |
2017-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
230,000 |
300,000 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
President and CEO |
• • – |
2016-12-07 |
4 |
B |
$2.14 |
$14,980 |
D/D |
7,000 |
70,000 |
2.81 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2016-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,466 |
4,048 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
President and CEO |
• • – |
2016-03-04 |
4 |
B |
$3.19 |
$9,570 |
D/D |
3,000 |
63,000 |
2.81 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
President and CEO |
• • – |
2016-01-22 |
4 |
B |
$2.38 |
$23,800 |
D/D |
10,000 |
60,000 |
2.81 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
President and CEO |
• • – |
2016-01-15 |
4 |
B |
$2.08 |
$20,800 |
D/D |
10,000 |
50,000 |
2.81 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2015-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,582 |
2,582 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
President and CEO |
• • – |
2015-05-06 |
4 |
B |
$3.73 |
$111,900 |
D/D |
30,000 |
40,000 |
2.81 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
President and CEO |
• • – |
2014-07-11 |
4 |
B |
$5.93 |
$59,280 |
D/D |
10,000 |
10,000 |
2.81 |
- |
|
| ABIO |
Nuvelo Inc |
Director |
– • – |
2010-03-29 |
4 |
S |
$7.30 |
$1,554,954 |
I/I |
(210,809) |
491,889 |
0 |
- |
|
| ABIO |
Nuvelo Inc |
Director |
– • – |
2009-01-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
702,698 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
